Insights & Resources
Perspectives, reports, and research from the Atacana team built for the senior leaders navigating the most complex commercial decisions in the industry.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Explore Our Content
Navigating the Obesity Market: An Overview of Current and Future Trends
Atacana Group
•
July 9, 2024
An Overview of Current and Future Trends
Reports
Cardiovascular
‘Moderna’izing Health
Atacana Group
•
June 12, 2024
Moderna’s impressive portfolio leveraging cutting-edge innovation propels it as a noteworthy competitor to industry giants like Pfizer, Sanofi, AstraZeneca, and GSK.
Reports
Vaccines
Rezdiffra: SWOT Analysis and Strategic Evaluation
Atacana Group
•
May 31, 2024
Big strides in MASH treatment with Madrigal Pharmaceuticals’ Rezdiffra! But… is this the best there is?
Reports
Strategy
Cardiovascular
Antibacterial Vaccines Catalysts
Atacana Group
•
May 8, 2024
Explore the future of the global antibacterial vaccine market, anticipating growth from $22B to $40B by 2030, unveiling a lucrative landscape ripe for innovation.
Reports
Vaccines
Antiviral Vaccines 2024 & 2025 Catalysts Report
Atacana Group
•
April 19, 2024
The Leading companies in the Antiviral Vaccine market, such as Pfizer, Moderna, GSK, and AstraZeneca are anticipating pivotal advancements, including regulatory milestones, clinical trial updates, and strategic product launches.
Reports
Vaccines
.avif)